QQ客服 官方微博 反馈留言

	Prevention of hepatitis C virus infection by adoptive allogeneic immunotherapy using suicide gene-modified lymphocytes: an in vitro proof-of-concept
	Leboeuf, C.; Roser-Schilder, J.; Lambotin, M.; Durand, S.; Wu, T.; Fauvelle, C.; Su, B.; Bole-Richard, E.; Deschamps, M.; Ferrand, C.
刊名	GENE THERAPY
	2015
卷号	22期号:2
ISSN号	0969-7128
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3435670
专题	昆明医科大学
推荐引用方式 GB/T 7714	Leboeuf, C.,Roser-Schilder, J.,Lambotin, M.,et al. Prevention of hepatitis C virus infection by adoptive allogeneic immunotherapy using suicide gene-modified lymphocytes: an in vitro proof-of-concept[J]. GENE THERAPY,2015,22(2).
APA	Leboeuf, C..,Roser-Schilder, J..,Lambotin, M..,Durand, S..,Wu, T..,...&Robinet, E..(2015).Prevention of hepatitis C virus infection by adoptive allogeneic immunotherapy using suicide gene-modified lymphocytes: an in vitro proof-of-concept.GENE THERAPY,22(2).
MLA	Leboeuf, C.,et al."Prevention of hepatitis C virus infection by adoptive allogeneic immunotherapy using suicide gene-modified lymphocytes: an in vitro proof-of-concept".GENE THERAPY 22.2(2015).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。